| Literature DB >> 28344478 |
Vira Lubenets1, Sofiya Vasylyuk1, Nataliya Monka1, Khrystyna Bolibrukh1, Olena Komarovska-Porokhnyavets1, Diana Baranovych1, Rostyslav Musyanovych1, Ewa Zaczynska2, Anna Czarny2, Urszula Nawrot3, Volodymyr Novikov1.
Abstract
A series of esters of 4-acetyl, 4-trifluoroacetyl- and 4-(3-chloropropionyl)aminobenzenethiosulfoacids (twenty-four compounds) were synthesized and characterized by elemental analysis, 1H NMR and IR spectroscopy. The antibacterial activity of the novel candidates has been screened using the agar diffusion or serial dilution methods against representative Gram-positive (Staphylococcus aureus, Bacillus subtilis, Bacillus mesentericus, Mycobacterium sp., Mycobacterium luteum), Gram-negative (Aeromonas sp., Burkholderia cepacia, Alcaligenes faecalis, Pseudomonas aeruginosa, Escherichia coli, Proteus vulgaris) bacteria and fungi (Candida albicans, Candida tenuis, Candida glabrata, Verticillium dahliae, Trichophyton gypseum, Aspergillus niger, Aspergillus fumigatus, Penicillium chrysogenum). Particular potency has been discovered against all tested pathogenic bacteria and fungi by compounds 1l and 3l at nanomolar concentrations. Some appropriate effect of thiosulfoesters structure upon their antimicrobial activity was determined.Entities:
Keywords: Antimicrobial activity; Bactericidal activity; Fungicidal activity; Thiosulfoacid derivatives; Thiosulfoesters
Year: 2016 PMID: 28344478 PMCID: PMC5355547 DOI: 10.1016/j.jsps.2016.06.007
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Scheme 1Structures of compounds 1, 2 and 3.
Structures of compounds 1a-o, 2a,b and 3a,d-f, l-n.
| Compounds | R | |
|---|---|---|
| CH3 | ||
| C2H5 | ||
| C3H5 | ||
| C3H7 | ||
| C4H9 | ||
| CH2COOCH3 | ||
| CH2-CH(OH)-CH2Cl | ||
| cycl-C5H9 | ||
| cycl-C6H11 | ||
| C6H5 | ||
| C6H4Cl-4 | ||
| C6H4NO2-4 | ||
| C6H4NO2-2 | ||
| CH3 | ||
| C2H5 | ||
| CH3 | ||
| C3H7 | ||
| i-C3H7 | ||
| C4H9 | ||
| C6H5 | ||
| C6H4Cl-4 | ||
| C6H4NO2-4 | ||
Parameters of result evaluation by the method of compound diffusion in agar.
| No | Zone diameter of microorganism growth inhibition, mm | Degree of microorganism sensitivity |
|---|---|---|
| 1. | 11–15 | Low-sensitive |
| 2. | 16–25 | Sensitive |
| 3. | >25 | Highly sensitive |
Scheme 2General synthesis of acylaminobenzenethiosulfoacid esters 1a-o; 2a,b and 3a, d-f, l-n.
Antibacterial and antifungal activities of investigated compounds by the diffusion method (method A).
| Compound | Concentration, % | Diameter of inhibition zones of growth of microorganism, mm | ||||||
|---|---|---|---|---|---|---|---|---|
| Fungi | Bacteria | |||||||
| A | B | C | D | E | F | G | ||
| 0.5 | 8 | 10 | 10 | 14 | 15 | 16 | 16 | |
| 0.1 | 0 | 0 | 0 | 8 | 10 | 10 | 12 | |
| 0.5 | 16 | 17 | 14 | 12 | 13 | 13 | 18 | |
| 0.1 | 7 | 8 | 0 | 9 | 9 | 9 | 12 | |
| 0.5 | 16 | 19 | 18 | 13 | 15 | 15 | 24 | |
| 0.1 | 7 | 8 | 7 | 9 | 9 | 7 | 10 | |
| 0.5 | 12 | 13 | 12 | 8 | 11 | 14 | 21 | |
| 0.1 | 8 | 10 | 8 | 0 | 8 | 8 | 10 | |
| Ethylthiosul fanylate | 0.5 | 27 | 16 | 20 | 29 | 19 | 17 | 25 |
| 0.1 | 13 | 0 | 12 | 18 | 17 | 16 | 17 | |
A: Candida tenuis VCMY-70; B: Aspergillus niger VCMF-1119; C: Penicillium chrysogenum VCMF-245; D: Escherichia coli C-600; E: Bacillus mesentericus; F: Staphylococcus aureus; G: Mycobacterium luteum B-917.
Values of minimal inhibitory concentrations (MIC, μM) determined by the serial dilution method (methods B and C).
| Compound | MIC | ||||||
|---|---|---|---|---|---|---|---|
| Fungi | Bacteria | ||||||
| A | B | C | D | E | F | G | |
| 0.2 | – | 0.1 | 0.41 | 4.08 | – | – | |
| 0.1 | – | 0.05 | 3.86 | 3.86 | – | – | |
| 0.37 | – | 0.05 | 3.69 | 3.69 | – | – | |
| – | – | – | – | – | 0.31 | 0.31 | |
| 0.17 | 0.33 | 0.08 | – | – | – | – | |
| 0.16 | 0.16 | 0.08 | – | – | – | – | |
A: Candida albicans ATCC 90028; B: Candida glabrata ATCC 90030; C: Aspergillus fumigatus IHEM 13934.
D: Burkholderia cepacia; E: Alcaligenes faecalis; F: Aeromonas sp. 9615; G: Escherichia coli C-600.
Not tested.
Values of minimal bactericidic and fungicidic concentrations (MBC and MFC, μM) determined by the serial dilution method (method B).
| Compound | MFC | MBC | |||||||
|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | H | I | |
| 0.41 | 0.16 | 0.8 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | |
| 0.15 | 0.15 | 0.04 | 0.15 | 1.54 | 0.08 | 0.08 | – | – | |
| 0.07 | 0.03 | 0.03 | 0.03 | 1.39 | 0.03 | 0.03 | 0.7 | 1.39 | |
| 0.01 | – | – | 0.03 | – | – | 0.03 | – | – | |
| 0.01 | – | – | 0.06 | – | – | 0.32 | – | – | |
| 0.03 | 0.01 | 0.01 | 0.03 | – | 0.07 | 0.01 | – | – | |
| 0.03 | 0.01 | 0.06 | 0.01 | – | 0.29 | 0.01 | – | – | |
| – | – | – | 1.14 | 1.14 | – | – | – | 0.28 | |
| – | 1.14 | 0.11 | – | 1.14 | – | 1.14 | – | 0.28 | |
| 0.14 | 0.14 | – | 1.36 | 1.36 | 1.36 | 1.36 | – | – | |
| 1.24 | 0.62 | 0.62 | 0.31 | 1.24 | 0.62 | 0.62 | – | – | |
| 0.62 | – | – | 0.62 | 1.24 | 1.24 | 0.62 | 1.24 | – | |
| 1.19 | – | – | 0.12 | – | 0.06 | 0.29 | – | – | |
| 0.11 | 0.03 | 0.03 | 0.06 | – | 0.06 | 0.11 | – | – | |
| 0.51 | 0.51 | 0.26 | 0.02 | – | – | 0.51 | – | – | |
| 0.49 | 0.25 | 0.49 | 0.25 | – | – | 0.49 | – | – | |
A: Candida albicans; B: Verticillium dahliae; C: Trichophyton gypseum; D: Staphylococcus aureus; E: Pseudomonas aeruginosa; F: Bacillus subtilis; G: Mycobacterium sp.; H: Escherichia coli; I: Proteus vulgaris.
Not tested.